Hot spots in TAFIa.
See also Sanglas L, Arolas JL, Valnickova Z, Aviles FX, Enghild JJ, Gomis-Rüth FX. Insights into the molecular inactivation mechanism of human activated thrombin-activatable fibrinolysis inhibitor. This issue, pp 1056-65.
Gils
A
A
Laboratory for Pharmaceutical Biology, Faculty of Pharmaceutical Sciences, Katholieke Universiteit Leuven, Leuven, Belgium. Ann.Gils@pharm.kuleuven.be
D025901:Carboxypeptidase B2 / Q000378:metabolism*; D006801:Humans; D011485:Protein Binding
D025901:Carboxypeptidase B2